Bristol-Myers Squibb Co [BMY] stock Upgrade by Jefferies analyst, price target now $70
Bristol-Myers Squibb Co [NYSE: BMY] price surged by 3.67 percent to reach at $2.05. The one-year BMY stock forecast points to a potential upside of 4.79. The average equity rating for BMY stock is currently 2.59, trading closer to a bullish pattern in the stock